Informa Pharma Intelligence Podcast

The Informa Pharma Intelligence Podcast is a round table discussion focusing on recent events in the healthcare space, published monthly by thought leaders at Informa Pharma Intelligence.

In this month’s episode, Pammy Spicer, Molly Nelson, Joe Haas, and Mike Ramirez discuss the following topics:

• Failure of aducanumab: Pammy Spicer discusses the high-profile failure of aducanumab, as well as the impact on the amyloid hypothesis, the mainstream concept underlying Alzheimer’s disease for over 20 years (1:39)
• Preview of Meddevicetracker report on device regulatory timing: Molly Nelson shares insights from an upcoming report dissecting time to approval for medical devices through different approval pathways and therapeutic areas (19:51)
• Recent results for Ocaliva (OCA) in non-alcoholic steatohepatitis (NASH): Joe Haas discusses recent results surrounding OCA, the reaction from the investment community, and the competitive landscape in NASH, a disease with no FDA-approved therapies (33:41)

A full transcription of the discussion can be downloaded via the report PDF link.